Bluestein R H & CO LLC Abbott Laboratories Transaction History
Bluestein R H & CO LLC
- $1.61 Billion
- Q3 2022
A detailed history of Bluestein R H & CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bluestein R H & CO LLC holds 329,514 shares of ABT stock, worth $42.2 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
329,514
Previous 345,860
4.73%
Holding current value
$42.2 Million
Previous $37.6 Million
15.15%
% of portfolio
1.98%
Previous 2.31%
Shares
18 transactions
Others Institutions Holding ABT
# of Institutions
3,577Shares Held
1.38BCall Options Held
9.72MPut Options Held
8.83M-
Vanguard Group Inc Valley Forge, PA170MShares$21.7 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.8 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$9.94 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA66.8MShares$8.55 Billion1.82% of portfolio
-
Capital Research Global Investors Los Angeles, CA50.7MShares$6.49 Billion1.53% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $224B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...